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Abstract
In the last years, Laboratory Information Management Systems (LIMS) have been
growing from mere inventory systems into increasingly comprehensive software plat-
forms, spanning functionalities as diverse as data search, annotation and analysis. Our
institution started in 2011 a LIMS project named the Laboratory Assistant Suite with the
purpose of assisting researchers throughout all of their laboratory activities, providing
graphical tools to support decision-making tasks and building complex analyses on
integrated data. Themodular architecture of the system exploits multiple databases with
different technologies. To provide an efficient and easy tool for retrieving information
of interest, we developed the Multi-Dimensional Data Manager (MDDM). By means
of intuitive interfaces, scientists can execute complex queries without any knowledge
of query languages or database structures, and easily integrate heterogeneous data
stored in multiple databases. Together with the other software modules making up the
platform, the MDDM has helped improve the overall quality of the data, substantially
reduced the time spent with manual data entry and retrieval and ultimately broadened
the spectrum of interconnections among the data, offering novel perspectives to the
biomedical analysts.
Database URL: https://github.com/lasircc/las-docker
Introduction
The introduction of automation and high-throughput
technologies in laboratory environments has raised diverse
issues related to the amount and heterogeneity of the
data produced, the adoption of robust procedures for
sample tracking and the management of computer-based
workflows needed to process and analyze the raw data.
Laboratory InformationManagement Systems (LIMS) have
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gained increasing popularity because they can ensure good
levels of quality control over the laboratory activities and
efficiently handle the large amounts of data produced (1).
LIMS aim at assisting the researchers in their daily lab-
oratory practice, improving the accessibility of the instru-
ments and tracking biological samples and their related
information.
In the past decade, several open-source as well as pro-
prietary LIMSs have been developed. Commercial solu-
tions are typically large, complex and feature-rich products
designed to easily support large laboratories. Their license
fees can be prohibitive, and extra features may come at
additional costs (2). To reduce these costs, the last gen-
eration of commercial LIMS adopt web-oriented software
technologies, particularly the software as a service distribu-
tion model, which reduces the customer’s final expenditure
on license fees, hardware and maintenance. Examples of
commercial solutions are STARLIMS (3), Exemplar LIMS
(4) and LabVantage SAPPHIRE (5).
Commercial LIMS tend to offer features based on com-
mon laboratory procedures and best practices, which may
not fit highly specific settings well. For instance, LabVan-
tage SAPPHIRE provides a large set of features, such as
sample and batch management, Quality Control, advanced
storage and logistics and task scheduling. However, the
life cycle of xenopatients (i.e. biological models for cancer
research based on the transplantation of human tumors
in mice) is not available in the standard software and
should be implemented as a custom module by the software
house. Another issue that affects commercial LIMSs is the
management and standardization of genomic data. To the
best of our knowledge, these systems do not exploit any
knowledge base related to the genomic data and do not
provide any validation and analysis of different genomic
data stored in the system.
Other products focus instead on specific sub-domains,
such as Galaxy LIMS (6, 7), addressing DNA sequencing
and annotation, or SeqWare (8), tracking in vivo and in
vitro experiments and building complex analysis work-
flows.
For this reason, many institutions have invested in the
development of in-house solutions and/or have adapted
open-source projects to their own requirements. In this way,
the developed solutions can provide functionalities that
meet the specific needs of the researchers in their institution
laboratories. From an engineering perspective, developing
in-house solutions may also permit to explore and adopt
new technologies, in order to define better data models and
improve system performance.
To address a substantial mismatch between the LIMS
solutions on offer and the functional requirements dic-
tated by research practice, in 2011 the Institute for Cancer
Research at Candiolo (Italy) started to implement its own
LIMS, named the Laboratory Assistant Suite (LAS) plat-
form (9). The main purpose of the platform was to assist
researchers in different laboratory and research activities,
allowing management of different kinds of raw data (e.g.
biological,molecular), tracking experimental data, support-
ing decision-making tasks and integrating heterogeneous
data for complex analyses. As development progressed,
several new features and modules were included to (i) track
clinical data, (ii) include support to the newest technologies
exploited for molecular experiments and (iii) standardize
the description of genomic data by means of semantic web
technologies. Thanks to these new features, scientists can
gain better insight into tumor development by jointly study-
ing the clinical evolution of the disease and the experimen-
tal results derived from in vivo/in vitro experimentation.
The experimental pipelines exploited in the translational
research context are the primary focus of the LAS, which
targets the standardization of the genomic data to allow a
comparison of results coming from different technologies.
Still, unlike the other commercial and open-source plat-
forms, the LAS makes an attempt at covering a wide range
of diverse laboratory procedures and, thanks to its versatile
and general-purpose structure, it can be extended to support
new ones with a limited effort.
Thanks to the vast variety of different experimental
technologies supported by the LAS and their high level of
specificity, large amounts of heterogeneous and complex
information are collected in separate databases. To enable
the users to extract and correlate information from the
different databases exploited by the platform, a Multi-
Dimensional Data Manager (MDMM) module was devel-
oped. The module takes care of merging data from the
different LAS databases, and provides a simple graphical
user interface to extract the information of interest without
any knowledge of a query language. A tool to visualize
biological entities and their related information with a hier-
archical tree structure is also available,while other powerful
visualization tools are currently under development. To the
best of our knowledge, no similar tools applied to biological
data and distributed databases exist.
The paper presents the main characteristics of the LAS
and its exploitation in the research laboratories of the Insti-
tute for Cancer Research at Candiolo and its research part-
ners. Next, the main features of the MDDM are described.
Finally, current and future research directions are presented.
LAS
Translational research aims at enhancing patient care,
transferring scientific discoveries from the laboratory to
a real clinical context. It is a kind of metaphorical scientific
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cycle from bench to bedside and back again through
complex iterative processes, operating between laboratory
(i.e. preclinical research) and clinic. To the aim of managing
and integrating preclinical and clinical information, a
robust but flexible data management platform is needed.
In particular, different types of information (e.g. biological
data, molecular data, procedure tracking data and sample
tracking data), some of which can be highly complex,
should be independently managed by the platform but,
at the same time, interconnected to permit integrated
analyses.
The LAS platform is freely available upon request to
the authors. The software is distributed by means of a
Docker-based approach to allow interested organizations
to configure it according to their constraints. Moreover,
the exploitation of Docker allows system administrators
to run the software on different servers using the Docker
Swarm configuration for balancing the workload as well as
data resources. We usually recommend to install the LAS
on at least two servers, one dedicated to the containers
running the software and the other for databases. The
servers characteristics depend on several aspects, such as
the number of simultaneously logged users, the number of
biological entities tracked and the dimension of raw data
stored. We suggest as initial setup a server with at least
16 GB of RAM and a storage space of 2 TB. Interested
users may refer to the video tutorials (available at the URL:
http://lasrep.ircc.it/) to explore main system features and
as a reference guide during its usage. The documentation
of the platform is provided with the software and can be
downloaded from the documentation section of the LAS
instance of the Institute for Cancer Research at Candiolo
(https://las.ircc.it/).
In the following,we present the data architecture and the
main functionalities included in the platform.
Data models
The LAS platform has been developed using different
database technologies to fit the needs of the application,
and to handle in a suitable way the heterogeneous data
characteristics.
The platform makes use of relational databases to track
biological entities and their properties, and the informa-
tion about the various experimental procedures. Since the
platform includes different modules managing substantially
different types of entities and/or specific laboratory pro-
cedures, different database instances are exploited. The
core biological entities (i.e. Aliquot, Biomouse and Cell
Line) are identified by a unique and mnemonic key, named
GenealogyID, that encodes relevant information regarding
the history of the entity. This key is automatically generated
by the LAS platform through formal rules and may be used
to link the data across the databases.
Parallel to the relational databases storing operating
data, a graph database is exploited. It is used to represent
the complex inherent hierarchy of biological entities and
their relationships. Being able to easily and efficiently
reconstruct the genealogical tree of each entity is indeed
an essential feature of the platform, allowing the user to
perform ad hoc queries and to isolate specific sub-trees of
biological entities involved in the experimental pipeline.
Moreover, the graph database has been exploited to store
a knowledge base for the heterogeneous domains managed
by the LAS modules. By using a graph representation,
all these domains can be easily interconnected, while the
knowledge base can be continuously updated and aug-
mented with new layers of information and different levels
of abstraction (e.g. proteomics, clinical, etc.). Finally, a
social network of users and research groups using the
LAS platform is also stored in the graph, to model data
ownership, resolve data access conflicts and manage
data sharing and collaboration among different groups
or users.
A document database, MongoDB, is also used to store
files associated with biological entities and metadata gener-
ated by both the LAS Genomic Data Manager modules and
the MDDM. The latter usage will be discussed in detail in
the next section.
Functionalities
The LAS architecture includes a set of software modules, i.e.
fully-fledged web applications, each addressing a different
type of biological entity and its associated experimental
procedures.Modules may interact with each other bymeans
of web APIs, e.g. to exchange data and/or to carry out oper-
ations that span multiple entities or domains. The modules
currently included in the LAS platform are described in the
following.
Even if the platform has been developed since 2011,
we always took into account security issues during the
design and development processes of the platform. In this
way, our software is compliant with the constraints of the
General Data Protection Regulation (GDPR), enforced on
25 May 2018. Indeed, the management of data produced
by different users and/or groups requires that the access to
functionalities and information are restricted according to
several criteria such as group and/or project membership,
and user role. For these reasons, the platformmanages users
and their privileges following these concepts:
• Working Group: A Working Group (WG) is a set of users
in the LAS platform that work together toward a specific
goal (e.g. project, research activity). The data produced
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by the users of the same group are private, unless they
intentionally share data with other groups.
• User Profiles: Each user belonging to a WG has a set of
permissions to access the LAS functionalities they have
been enabled to use. These functionalities are defined
according to the role selected during the user registration
process. The manager of her/hisWG or the system admin-
istrator can assign new functionalities upon request.
To collect data, the user is supposed to specify the
Informed Consent signed by the patient for specific research
activities (e.g. preclinical trials) involving personal samples
and information. This document is defined by a committee
to accomplish all the constraints included in the GDPR.
Since the data are collected for research purposes, the
patient can only revoke the usage of the biological sam-
ples, but not the information (e.g. experimental results)
collected by the researchers. Only the researchers that are
included in the research project can manage these samples
and track the experimental processes according to their
profile. The platform tracks all the procedures performed
by each user in order to identify malicious usage of the
software.
The Clinical Module tracks for each patient both con-
text information (i.e. personal data, Medical Center of
the Trial, etc.) and relevant clinical events through Case-
Report-Form. All data are related to the relative Informed
Consent that grants data and specimens sampling.
The BioBanking Management Module covers a wide
range of activities, including management of biological
samples and associated pathological information, as well as
support to a number of laboratory-related procedures. For
instance, the module can handle the collection of biological
material from surgical intervention and the acquisition of
aliquots from external laboratories. Aliquots stored in the
system are characterized by features such as tumor type
(e.g. colorectal), tissue type (e.g. liver metastasis), source
hospital or laboratory and pathological information. Mea-
surement of aliquot physical characteristics, such as volume,
concentration, purity and quality can be tracked by the
module, as well as the derivation of new biological materials
(e.g. DNA and cDNA) and the planning of molecular
experiments.
The biological material used in our laboratories is stored
by means of several types of containers (e.g. freezers, racks,
plates and tubes). Their mutual interactions (i.e. which
types of containers can host other containers) can change
according to characteristics such as the layout and the
laboratory procedure. The Storage Management Module
allows managing any kind of container by defining and
applying different rules to them, and tracks the relationships
between the containers and the biological entities.
Different types of molecular analyses can be conducted
on biological samples, to investigate various aspects of
their genetic constituents that may have an impact on the
development of oncogenic behavior. For instance, biologists
may be interested in analyzing mutations for a target gene
involved in tumor proliferation. In an effort to closely
track the translational research pipeline from the collection
of samples to their analysis, the LAS provides support
to tracking the most frequently used molecular profiling
techniques in our institution [e.g. Sanger sequencing, real-
time polymerase chain reaction (PCR) and Sequenom].
Each molecular module queries the Knowledge Base of
the Genomic Annotation Manager (GAM) to retrieve the
description of its reagents, as well as a specification of all
possible alterations (e.g. sequence alterations and gene copy
number variations) known in the literature, to allow both
the experiment definition and the evaluation of experimen-
tal results.
The GAM provides a higher-level, qualitative insight
into the genomic features of biological samples. This infor-
mation is shaped in the form of annotations, i.e. a set of
semantic labels attached to a sample, pointing out some
of its relevant features. To ensure semantic coherence and
adopt a standardized nomenclature, all relevant concepts
from the genomic and biological domains used for labeling
samples have been drawn from a number of public, freely
accessible databases and ontologies (10–13). This informa-
tion has been structured into a knowledge base, modeled
as a graph and stored in a graph database (14). Concepts
are interlinked with one another, according to both general-
purpose semantic relationships such as containment (‘part
of’) or generalization (‘is a’), and domain-specific relation-
ships (e.g. indicating an underlying biochemical process, as
in ‘is transcribed from’). New concepts and relationships, as
well as new domains of interest, may be added or layered
as needed, to account for novel findings and broaden the
spectrum of investigation. Within the GAM, every anno-
tation is a semantic statement establishing a relationship,
expressed by means of a predicate, between a biological
sample (the subject of the statement) and a concept (the
object of the statement), such as a genetic mutation. It is
represented within the graph database as a node of type
‘annotation’ with a pair of incoming and outgoing edges—
one linking the biological sample to the annotation node
by means of a ‘has annotation’ relationship, and the other
linking the annotation node to the reference node in the
knowledge base by means of a ‘has reference’ relationship.
The annotation node is often linked to other nodes, such
as the process that produced the annotation or the raw
experimental data.
Finally, the platform allows tracking in vivo and in vitro
experiments. ‘In vivo’ (Latin for ‘within the living’) studies
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Figure 1. MDMM architecture.
are those in which the effects of various biological entities
are tested on whole, living organisms—usually animals
(e.g. xenopatients). This kind of experiments are normally
exploited to test drug therapies and expand the collection
of biological samples. We based our development on the
model described in (15) to manage immunocompromised
animals and monitor the xenopatient life cycle, from their
acquisition by the research institute to their death. Unlike
in vivo experiments, in vitro studies are performed with
cells or biological molecules studied outside their normal
biological context. The LAS platform defines a Cell Line
as the set of biological entities that are generated from the
same biological entity and are under the same experimental
conditions. The experimental conditions are defined by the
protocols that describe the type of process (i.e. adherent,
suspend and organoid) and the set of culturing conditions
applied (e.g. nutrients and chemicals, hormones/growth
factors and antibiotics). In addition, the platform allows the
management of the generation and thawing procedures of
cell lines.
MDDM
Besides tracking experimental procedures and recording
all the data related to biological entities, the retrieval of
the information tracked by the platform is fundamental
to discover new knowledge related to tumors. Due to the
large number of laboratory activities and biological entities
managed by the LAS with a high level of specificity, and to
streamline the development and maintenance process over
time, each LAS module operates on a separate database
instance, storing both operational data and domain-specific
knowledge, and partially replicating key information from
other LAS modules. As a result, while each instance
focuses on its own specific subset of functionalities, no
one database can provide a comprehensive insight into
the data. Nonetheless, building actionable knowledge
requires the integration of heterogeneous information
to establish connections among different and related
biological entities, or to explore different facets of the same
entities, both for operational and for research purposes.
For instance, identifying the number of tubes stored in
each plate of a given freezer and their content may be
required for managing physical storage equipment. From a
researcher’s perspective, the study of the evolution of the
tumor mass in a mouse under pharmacological treatment
(monitored by means of in vivo experimentation and
tracked by the Xenograft Management Module) must be
traced back to the originating patient (managed by the
Clinical Module), and should be further correlated to
the mouse genomic mutational status and gene expres-
sion levels (collected by the set of Molecular Modules
and annotated by the Genomic Annotation Module).
The MDDM addresses the issue of extracting all
information of interest stored in the databases of each LAS
module, providing the end user with an intuitive graphical
tool for building customized queries with a unified view on
the entire collection of databases. In addition, the MDDM
can be exploited to run programmatical queries via a set
of web APIs, enabling other LAS modules, as well as other
external applications, to retrieve data of interest.
Architecture
The MDDM has a distributed architecture. Its main com-
ponents, shown in Figure 1, are the central MDDM Data
Integrator (DI) module and the distributed MDDM Data
Provider (DP) modules. The DI module provides a unified
logical view on the databases of the other modules, thus
acting as a (read-only) federated database (16). The DP
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modules rely on a standalone application layer that must be
installed within each LAS module, allowing the LAS mod-
ules to join the federated database. Interactions between the
DI and the DP modules occur via two distinct sets of APIs.
The MDDM DP APIs are called by the central DI
module. They provide an interface to perform the fol-
lowing tasks. (i) Retrieve schema information from each
LAS module’s database. This operation is executed once at
setup time, when the LAS module is initially registered as a
member of the federated database. The APIs collect schema
information (i.e. database entities, entity attributes and rela-
tionships among entities) from the object-relational map-
ping layer provided by Django, the Python-based Model-
View-Controller (MVC) development platform of choice.
Thus, they are independent of the choice of the actual
DataBase Management System (DBMS) adopted as a stor-
age backend. These metadata, stored by the DI module in its
local database,will later be used to define the logical schema
of the federated database (see Section Logical design). (ii)
Run SQL queries on the LAS modules’ local databases and
return data to the DI module. Query requests are sent by
the DI module using an ad hoc, SQL-injection-proof pro-
tocol. To ensure higher flexibility and allow more complex
operations not well supported by the ORM layer, the API
speaks directly to the underlying DBMS using raw SQL
queries and a DBMS-specific library handling the slight
syntax variations among products. Currently only a library
for the MySQL database management system is available.
See Section Query execution for further details about the
query engine.
The MDDM DI APIs provide a programmatic interface
for executing complex queries on the federated database.
The queries that may be executed through this interface are
currently not free-form. Instead, they are template queries
that receive zero or more parameters and return a set of
rows by implementing a user-defined query flow. These
template query flows may be designed by the LAS users by
resorting to the Query Generator Graphical User Interface
(GUI) (see Section Query Generator for details). Thus, an
unlimited number of different queries may be designed and
run through this interface. In addition to an endpoint for
submitting query requests, the DI includes a set of APIs for
obtaining the list of available templates, and a structured
description of their input parameters and output schema.
In this way, hard coding of result parsing routines can be
avoided or at least reduced, since the data consumer can
automatically detect changes in the input parameters
or in the output fields, and take appropriate measures.
The DI APIs serve two main scenarios. (i) They are
used by LAS modules that need additional informa-
tion from other modules to accomplish their tasks.
The DI provides them with a unified, possibly aggre-
gated set of information by running an appropriate
query. (ii) They may be used by external services or
applications that need to query the data stored in the
LAS platform (e.g. collaborations with research partners,
running external pipelines or scripts).
Logical design
The MDDM provides a logical abstraction of the databases
of the different LAS modules taking part in the federated
database, which may be accessed seamlessly as a single
database. Initially, the MDDM DP APIs are installed in
each relevant LAS module. Next, each module’s database
is registered in the MDDM as a DP through an ad hoc
GUI, requiring the URL of the LAS module (which may
reside on a different server) and a number of configuration
parameters (such as a name, colors to be used by the Query
Generator GUI to draw the corresponding entity buttons,
etc.). The DP’s schema is contextually imported through
the DP API. Before the DP may be queried, a number
of Entities and Query Paths must be defined by an
experienced user (usually the database administrator, or
an experienced PI) using a dedicated administrative GUI.
Entities are classes of concepts and/or objects that are
relevant in the given context, similar to their namesakes
in the Entity–Relationship logical database model (17).
Within the MDDM, each Entity is based on an existing
table from the original DP database, but in order to
enhance its expressiveness, its attributes are not limited
to those included in the original DP table. Instead, any
attribute from a related (under the constraint that the
base table has a one-to-one or many-to-one relationship
with the related table) DP table may be used or combined
with other attributes to form an Entity attribute. Entity
attributes can be used to define filtering parameters and/or
output attributes for the Entity. Query Paths generalize
the relational notion of a foreign key, in that they dictate
how two different Entities A and B should be related to
each other. They are defined as the set of DP tables that
must be joined, through their foreign keys, in order to link
the base table of Entity A to the base table of Entity B.
Given an instance of Entity A, the maximum number of
instances of Entity B that correspond to it can be equal
to one (if the foreign key chain only includes many-
to-one or one-to-one relationships) or larger than one
(if it includes at least one one-to-many relationship).
Query Paths can be defined through an ad hoc interface.
To guide the user throughout this task, the MDDM can
automatically build a graph, whose nodes are DP tables
and edges are relationships between tables, and exploit a
shortest path algorithm to identify an optimal Query Path
between a pair of Entities. Alternatively, Query Paths can
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Figure 2. Query Generator interface.
be manually built by selecting the available foreign key
relationships.
Query Generator
The MDDM’s core feature is a tool to design queries.
The tool exploits a graphical metaphor based on cascaded
blocks that should be easily understood even by inex-
perienced users. Each query block represents one of the
federated database Entities, as previously described, or an
operator, and it defines which kind of object will be returned
as the block’s output. Available query blocks are shown
on the left-hand side of the editor (block A in Figure 2)
and categorized according to the DP from which the data
are drawn (e.g. the flask icon for Biobank data and the
mouse icon for xenopatient data). The user can drag and
drop the query blocks on the workflow editor (block B).
For instance, Figure 2 shows the xenopatients, also known
as patient-derived xenograft (PDX) models, and Explants
blocks from the Xenopatient DP, the Aliquots block drawn
from the Biobank DP and the Containers block from the
Storage DP. The reported query aims at retrieving all the
containers (e.g. tubes) carrying aliquots explanted from
PDX models. Filtering conditions may be specified for each
block by clicking the funnel icon. In the reported example,
the user can retrieve only the viable aliquots that are still
available. Set operators (Union, Intersection andDifference)
and special operators (Group-count, Extend and Template
blocks), listed on the right-hand side (block C in the figure),
can also be used. Blocks must be interconnected to build
a query workflow by drawing a wire between a block’s
output terminal and another block’s input terminal. Two
blocks may only be connected if a Query Path exists (as
defined by theMDDMadministrator) that instructs the sys-
tem how to match the corresponding Entities. Conversely,
an error message will be shown. Once a workflow has been
defined, the user may assign a title and a description to it
(block D), then either run the query immediately, or save
it in the system as a template, so that it can be run later
either through the Query Generator Template block, or
through the DI APIs. Furthermore, queries may be saved
as Translators, i.e. a special type of template that may be
optionally run for every row appearing in the result set of
a query, to enrich it with additional, related information.
Query results are displayed in a paged tabular structure.
Since they are stored in the document database (MongoDB),
they can be reopened at any time without re-running the
query. In addition, they can be exported in multiple formats
and saved locally by the user.
By using the Query Generator, the users can build
any kind of query disregarding the structure of the
databases, the query language and the low-level procedure
to connect data among several databases. For instance,
they can retrieve information about treatments performed
on xenopatients starting form a set of aliquots, the location
of aliquots generated by cell lines, the vital status of mice
belonging to a specific project andmany other data valuable
for daily work and for statistical analyses.
Query execution
The query flow designed by means of the Query Genera-
tor is structured as a sequence of interconnected blocks.
Internally, the query is represented as a tree, whose root
node is the end terminal and whose leaves are the start
terminals of each initial block. Thus, queries are executed
by depth-first traversing the query tree in post-order. For
each visited query block, the MDDM federated database
is accessed to identify the underlying DP tables. The query
block is translated into a relational query structure by
instantiating the required DP tables, setting the appropriate
join conditions, applying the query block parameters as
filtering conditions and adding aggregation operations (if
any). The choice of attributes selected from the DP tables
as the block outputs depends on whether the query block is
an intermediate block (thus only requiring the primary key
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Figure 3. Genealogy Tree Visualizer interface.
and any correlation attributes) or the final block (requiring
all attributes defined as outputs for the block). In addition,
the Query Path linking the current block to the next one is
loaded, and any other required DP tables are also instanti-
ated. Next, the query is sent to the DP through the APIs.
If both the current block and its successor reside in the
same DP, the DP APIs will not issue a real query to the
underlying DBMS, but will create a logical view wrapping
the query. Conversely, if the successor block belongs to a
different DP, a query is issued, and result rows are returned
to the MDDM. When backtracking to the successor block,
the results are sent to the DP together with the new query
and inserted in an indexed temporary table that is joined
with the rest of the query schema. This generally improves
the performance of cross-DP queries. In many cases, the
Genealogy ID is used as a key to link Entities belonging to
different DPs. As a last step, translator templates selected
by the user (if any) are run on the result set. Template
queries are managed by storing the tree structure of the
corresponding query in the MDDM database. The tree is
reloaded at each template execution, and its parameters
are populated. Next, the tree is traversed as previously
described.
Visualization tools
As outlined in the introduction, translational pipelines, i.e.
the laboratory practice of transplanting tumor specimens
into different organisms or environments to study their
proliferation, are of vital importance to cancer research.
Therefore, practitioners need effective tools to examine
the complex hierarchies of biological entities involved in
the pipelines. The MDDM addresses this requirement with
the Genealogy Tree Visualizer. The rationale is to lever-
age the intrinsic hierarchical structure of the xenopatient
pipeline to produce a graphical tree representation capable
of highlighting (i) father–child relationships among xenopa-
tients, and (ii) multiple layers of relevant features for each
individual, by exploiting a succinct but intuitive visual
encoding relying on shapes, sizes, colors and tooltips.When
the user inputs a collection identifier using a Genealogy
ID prefix (e.g. CRC0080), the system extracts relevant
data from the MDDM federated database by exploiting
dedicated templates, run through the DI APIs. Thus, by
modifying such templates, the tool can be easily extended
to integrate and visualize additional information. Next,
xenopatients are automatically partitioned based on differ-
ent features (i.e. the type of tissue from which the original
human tumor was collected, and the lineage), and individ-
ual hierarchical trees are constructed. The result is directly
shown to the user, who may customize the visualization to
her liking.
An example is shown in Figure 3. Some of the features
of each xenopatient are always visible (i.e. the shape,
indicating the availability of vital material for the xenopa-
tient, and the size, indicating the number of specimens
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Table 1. Aliquots statistics based on their type
Human Xenopatients Cell lines
Complementary DNA 0 1414 74
Complementary RNA 14 1470 0
DNA 17 966 28 240 945
Formalin fixed 1454 22 911 336
Frozen 733 0 0
Frozen sediment 78 0 0
Labeled section 106 3192 0
OCT frozen 1 338 0
Protein 0 0 129
Plasma 36 220 185 0
Paraffin section 107 3478 0
RNA Later 9455 56 493 11
RNA 379 8449 617
Snap frozen 1453 49 282 134
Viable 8901 30 126 10 032
Total 76 867 205 578 12 278
Table 2. Number of aliquots used for each experiment
Experiment #Aliquots
Beaming 33
DigitalPCR 33
Histology-IHC 3939
MicroArray 276
RealTimePCR 3764
SangerSequencing 808
Sequenom 10 508
WesternBlots 75
Collaboration (external) 11 264
collected from the xenopatient and available in the
biobank), while others, exploiting different color coding
schemas, can be layered on demand. The tool can currently
visualize or highlight (i) treated, untreated and historical
(i.e. prior to the introduction of the LAS platform and,
hence, not comprehensively tracked) xenopatients, (ii)
experimental treatment protocols applied by practition-
ers, (iii) xenopatients satisfying certain treatment and
biological material availability conditions and (iv) the
path from a given xenopatient to its root ancestor. In
addition, statistics about treatment protocols are provided
(not shown in Figure 3), whereas details about each
xenopatient is displayed as a tooltip when hovering
over the corresponding node. To limit the number of
individuals, which can become overwhelming, the tree may
be pruned by removing disconnected nodes without any
treatments. Furthermore, father–child relationships that
are missing for historical xenopatients can be manually
defined.
Platform usage
The LAS platform has been actively employed for research
in the Institute for Cancer Research at Candiolo since
March 2012.Only a fewmodules (e.g. BioBanking, Storage)
have been available in the first release, with a subset of the
current features, while the modules addressing the molec-
ular experiments were introduced in 2013. During the last
years, more functionalities have been developed to improve
the user experience and provide new functionalities to track
more information about biological entities and their life
cycles. Within our institution, a number of research groups
are currently using the platform, and a large amount of
data has already been produced and stored. In particular, as
of November 2018, the researchers defined approximately
10 800 collections, each one including all biological entities
(i.e. aliquots and PDXs) that share a common origin (i.e. the
same collection event). The BioBanking module currently
stores approximately 300 000 aliquots of different types, as
pointed out in Table 1. On average, 3200 aliquots are gen-
erated each month from surgical interventions on human
patients, xenopatients, cell line thawing and derivation
procedures. Since the most active user group works with
PDXs, ∼70% of the aliquots stored are generated from
mice. Derived aliquots represent ∼20% of the BioBank-
ing content, and most of them are DNA. The platform
also tracks aliquot consumption according to the types of
experiments as reported in Table 2.Approximately 37%are
sent to external laboratories to perform special analyses,
while all the other molecular experiments are performed
in our institution. The in vivo experiments represent one
of the main activities of our institution as well as the
plasma collection. Indeed, more than 44 000 mice have
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Figure 4. Mice status.
been tracked. Most of them have already been explanted
to generate new aliquots, while approximately 1700 mice
are currently under treatment with experimental drugs and
1500 are now implanted to expand the biological material.
A detailed categorization of mice statuses is reported in
Figure 4. At the moment of writing, more than 15 000
experimental treatments have been applied and 143 are still
under execution.
The MDDM module has been widely used in the past
years. We tracked more than 15 000 queries submitted by
the users from the Query Generator. This highlights the
relevance of this LAS module in the daily activities of our
institution.
The LAS platform has been changing the research
activities in our institution. We periodically ask users about
their opinion on diverse system features to understand
their impact on the daily work of researchers. Usually,
they answer that the system is proving very useful in
supporting their research, even if they met some difficulties
when they started using the platform. Indeed, they
admit that the LAS has changed their working habits
(e.g. users of the platform must follow predefined rules
and procedures for each operation, and instantly report
their activity). Furthermore, they noticed an improvement
in the data quality and a reduction of the time spent
in tracking data, especially when they work in critical
environments.
Due to the reliability of the system and the coverage of
laboratory procedures, the new EurOPDX Research Infras-
tructure adopted LAS as a LIMS for data management,
with LAS to be installed across the six nodes of the dis-
tributed infrastructure (www.europdx.eu).Our lab is one of
these nodes.
Conclusion
The LAS platform is designed to assist researchers of biolog-
ical and biomedical laboratories in all of their activities. The
modular architecture manages heterogeneous and complex
data and supports researchers and practitioners in per-
forming different experimental procedures. The graphical
interfaces and the web-based architecture are suitable for
use in diverse environments, including hostile ones (e.g. in
sterile conditions). Due to the modular architecture, a query
module has been developed to perform federated queries
over all the databases. Thanks to an intuitive graphical
interface, the users can design complex queries without
any knowledge of databases structures or query languages.
In addition, a visualization tool has been integrated in
the querying environment to generate targeted visual rep-
resentations of biological entities and their relationships,
allowing the scientists to extract relevant information for
further analyses.More visualization tools will be envisioned
in the near future.
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